Gut bacterial gene changes following pegaspargase treatment in pediatric patients with acute lymphoblastic leukemia

References

• Luengo A, Gui DY, Vander Heiden MG. Targeting metabolism for cancer therapy. Cell Chem Biol. 2017;24(9):1161–1180.
   PubMed Web of Science ®Google Scholar
• Hensley CT, Wasti AT, DeBerardinis RJ. Glutamine and cancer: cell biology, physiology, and clinical opportunities. J Clin Invest. 2013;123(9):3678–3684.
   PubMed Web of Science ®Google Scholar
• Kovacevic Z, McGivan JD. Mitochondrial metabolism of glutamine and glutamate and its physiological significance. Physiol Rev. 1983;63(2):547–605.
   PubMed Web of Science ®Google Scholar
• Windmueller HG, Spaeth AE. Uptake and metabolism of plasma glutamine by the small intestine. J Biol Chem. 1974;249(16):5070–5079.
   PubMed Web of Science ®Google Scholar
• DeBerardinis RJ. Is cancer a disease of abnormal cellular metabolism? New angles on an old idea. Genet Med. 2008;10(11):767–777.
   PubMed Web of Science ®Google Scholar
• Prager MD, Bachynsky N. Asparagine synthetase in normal and malignant tissues: correlation with tumor sensitivity to asparaginase. Arch Biochem Biophys. 1968;127(1):645–654.
   PubMed Web of Science ®Google Scholar
• Haskell CM, Canellos GP. Asparaginase and leukaemia. Lancet. 1969;1(7595):626.
   PubMed Web of Science ®Google Scholar
• Chiu M, Taurino G, Bianchi MG, et al. Asparagine synthetase in cancer: beyond acute lymphoblastic leukemia. Front Oncol. 2019;9:1480.
   PubMed Web of Science ®Google Scholar
• Silverman LB, Gelber RD, Dalton VK, et al. Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01. Blood. 2001;97(5):1211–1218.
   PubMed Web of Science ®Google Scholar
• Asselin BL, Lorenson MY, Whitin JC, et al. Measurement of serum L-asparagine in the presence of L-asparaginase requires the presence of an L-asparaginase inhibitor. Cancer Res. 1991;51(24):6568–6573.
   PubMed Web of Science ®Google Scholar
• Horvath TD, Chan WK, Pontikos MA, et al. Assessment of l-Asparaginase pharmacodynamics in mouse models of cancer. Metabolites. 2019;9(1):10.
   Web of Science ®Google Scholar
• Bäckhed F, Ley RE, Sonnenburg JL, et al. Host-bacterial mutualism in the human intestine. Science. 2005;307(5717):1915–1920.
   PubMed Web of Science ®Google Scholar
• Basson A, Trotter A, Rodriguez-Palacios A, et al. Mucosal interactions between genetics, diet, and microbiome in inflammatory bowel disease. Front Immunol. 2016;7:290.
   PubMed Web of Science ®Google Scholar
• Ridlon JM, Kang DJ, Hylemon PB, et al. Bile acids and the gut microbiome. Curr Opin Gastroenterol. 2014;30(3):332–338.
   PubMed Web of Science ®Google Scholar
• Belkaid Y, Harrison OJ. Homeostatic immunity and the microbiota. Immunity. 2017;46(4):562–576.
   PubMed Web of Science ®Google Scholar
• Li H, Jia W. Cometabolism of microbes and host: Implications for drug metabolism and drug-induced toxicity. Clin Pharmacol Ther. 2013;94(5):574–581.
   PubMed Web of Science ®Google Scholar
• Wilson ID, Nicholson JK. Gut microbiome interactions with drug metabolism, efficacy, and toxicity. Transl Res. 2017;179:204–222.
   PubMed Web of Science ®Google Scholar
• Liang D, Leung RK, Guan W, et al. Involvement of gut microbiome in human health and disease: brief overview, knowledge gaps and research opportunities. Gut Pathog. 2018;10:3.
   PubMed Web of Science ®Google Scholar
• Gevers D, Kugathasan S, Denson LA, et al. The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe. 2014;15(3):382–392.
   PubMed Web of Science ®Google Scholar
• Griffiths JA, Mazmanian SK. Emerging evidence linking the gut microbiome to neurologic disorders. Genome Med. 2018;10(1):98.
   PubMed Web of Science ®Google Scholar
• Nearing JT, Connors J, Whitehouse S, et al. Infectious complications are associated with alterations in the gut microbiome in pediatric patients with acute lymphoblastic leukemia. Front Cell Infect Microbiol. 2019;9:28.
   PubMed Web of Science ®Google Scholar
• Metges CC. Contribution of microbial amino acids to amino acid homeostasis of the host. J Nutr. 2000;130(7):1857S–1864S.
   PubMed Web of Science ®Google Scholar
• Metges CC, El-Khoury AE, Henneman L, et al. Availability of intestinal microbial lysine for whole body lysine homeostasis in human subjects. Am J Physiol. 1999;277(4):E597–E607.
   PubMedGoogle Scholar
• Dai ZL, Wu G, Zhu WY. Amino acid metabolism in intestinal bacteria: links between gut ecology and host health. Front Biosci. 2011;16:1768–1786.
   PubMed Web of Science ®Google Scholar
• Sridharan GV, Choi K, Klemashevich C, et al. Prediction and quantification of bioactive microbiota metabolites in the mouse gut. Nat Commun. 2014;5:5492.
   PubMed Web of Science ®Google Scholar
• Liu R, Hong J, Xu X, et al. Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention. Nat Med. 2017;23(7):859–868.
   PubMed Web of Science ®Google Scholar
• Kawase T, Nagasawa M, Ikeda H, et al. Gut microbiota of mice putatively modifies amino acid metabolism in the host brain. Br J Nutr. 2017;117(6):775–783.
   PubMed Web of Science ®Google Scholar
• Visconti A, Le Roy CI, Rosa F, et al. Interplay between the human gut microbiome and host metabolism. Nat Commun. 2019;10(1):4505.
   PubMed Web of Science ®Google Scholar
• Franzosa EA, McIver LJ, Rahnavard G, et al. Species-level functional profiling of metagenomes and metatranscriptomes. Nat Methods. 2018;15(11):962–968.
   PubMed Web of Science ®Google Scholar
• Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27–30.
   PubMed Web of Science ®Google Scholar
• Segata N, Waldron L, Ballarini A, et al. Metagenomic microbial community profiling using unique clade-specific genes. Nat Methods. 2012;9(8):811–814.
   PubMed Web of Science ®Google Scholar
• Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc. 1995;57(1):289–300.
   Google Scholar
• Dunn OJ. Multiple comparisons among means. JASA. 1961;56:54–64.
   Web of Science ®Google Scholar
• Holm S. A Simple sequentially rejective multiple test procedure. Scand J Stats. 1979;6:65–70.
   Web of Science ®Google Scholar
• Raina M, Ibba M. tRNAs as regulators of biological processes. Front Genet. 2014;5:171.
   PubMed Web of Science ®Google Scholar
• Avramis VI, Sencer S, Periclou AP, et al. A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study. Blood. 2002;99(6):1986–1994.
   PubMed Web of Science ®Google Scholar
• Appel IM, Kazemier KM, Boos J, et al. Pharmacokinetic, pharmacodynamic and intracellular effects of PEG-asparaginase in newly diagnosed childhood acute lymphoblastic leukemia: results from a single agent window study. Leukemia. 2008;22(9):1665–1679.
   PubMed Web of Science ®Google Scholar
• Angiolillo AL, Schore RJ, Devidas M, et al. Pharmacokinetic and pharmacodynamic properties of calaspargase pegol Escherichia coli L-asparaginase in the treatment of patients with acute lymphoblastic leukemia: results from Children's Oncology Group Study AALL07P4. J Clin Oncol. 2014;32(34):3874–3882.
   PubMed Web of Science ®Google Scholar
• Borek D, Michalska K, Brzezinski K, et al. Expression, purification and catalytic activity of Lupinus luteus asparagine beta-amidohydrolase and its Escherichia coli homolog. Eur J Biochem. 2004;271(15):3215–3226.
   PubMedGoogle Scholar
• Larsen RA, Knox TM, Miller CG. Aspartic peptide hydrolases in Salmonella enterica serovar typhimurium. J Bacteriol. 2001;183(10):3089–3097.
   PubMed Web of Science ®Google Scholar
• Lowenson J, Clarke S. Does the chemical instability of aspartyl and asparaginyl residues in proteins contribute to erythrocyte aging? The role of protein carboxyl methylation reactions. Blood Cells. 1988;14(1):103–118.
   PubMedGoogle Scholar
• Robinson NE, Robinson AB. Prediction of primary structure deamidation rates of asparaginyl and glutaminyl peptides through steric and catalytic effects. J Pept Res. 2004;63(5):437–448.
   PubMedGoogle Scholar
• Teshima G, Porter J, Yim K, et al. Deamidation of soluble CD4 at asparagine-52 results in reduced binding capacity for the HIV-1 envelope glycoprotein gp120. Biochemistry. 1991;30(16):3916–3922.
   PubMed Web of Science ®Google Scholar
• Chen Y, Dinges MM, Green A, et al. Absorptive transport of amino acids by the rat colon. Am J Physiol Gastrointest Liver Physiol. 2020;318(1):G189–G202.
   PubMed Web of Science ®Google Scholar
• Aoki T, Weber G. Carbamoyl phosphate synthetase (glutamine-hydrolyzing): increased activity in cancer cells. Science. 1981;212(4493):463–465.
   PubMed Web of Science ®Google Scholar
• Lee JS, Adler L, Karathia H, et al. Urea cycle dysregulation generates clinically relevant genomic and biochemical signatures. Cell. 2018;174(6):1559–1570.e22.
   PubMed Web of Science ®Google Scholar
• Keshet R, Szlosarek P, Carracedo A, et al. Rewiring urea cycle metabolism in cancer to support anabolism. Nat Rev Cancer. 2018;18(10):634–645.
   PubMed Web of Science ®Google Scholar
• Knott SRV, Wagenblast E, Khan S, et al. Asparagine bioavailability governs metastasis in a model of breast cancer. Nature. 2018;554(7692):378–381.
   PubMed Web of Science ®Google Scholar